Evaluation of the clinical efficacy of 1.2% atorvastatin in the treatment of periodontal intraosseous defects by CBCT: A randomized controlled clinical trial

Background. Atorvastatin (ATV), which belongs to the statin class of drugs, is the formidable inhibitor of 3-hydroxy-2- methyl-glutaryl coenzyme A reductase. This clinical trial evaluated and compared the clinical and radiographic changes in chronic periodontitis (CP) patients, obtained through 1.2%...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirke, Prerna Y., Kolte, Abhay P., Kolte, Rajashri A., Bawanakar, Pranjali V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904913/
https://www.ncbi.nlm.nih.gov/pubmed/31857864
http://dx.doi.org/10.15171/joddd.2019.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904913/
https://www.ncbi.nlm.nih.gov/pubmed/31857864
http://dx.doi.org/10.15171/joddd.2019.029

Ejemplares similares